Topical application of bacteriophages for treatment of wound infections.

Icon for Elsevier Science Related Articles

Topical application of bacteriophages for treatment of wound infections.

Transl Res. 2020 Mar 19;:

Authors: Chang RYK, Morales S, Okamoto Y, Chan HK

Abstract
Wound infections associated with multidrug-resistant (MDR) bacteria are one of the important threats to public health. Bacteriophage (phage) therapy is a promising alternative or supplementary therapeutic approach to conventional antibiotics for combating MDR bacterial infections. In recent years, significant effort has been put into the development of phage formulations and delivery methods for topical applications, along with preclinical and clinical uses of phages for the treatment of acute and chronic wound infections. This paper reviews the application of phages for wound infections, with focuses on the current status of phage formulations (including liquid, semi-solid and liposome-encapsulated formulations, phage-immobilized wound dressings), safety and efficacy assessment in clinical settings and major challenges to overcome.

PMID: 32268129 [PubMed - as supplied by publisher]